Ademetionine (SAMe)

Mechanism of action

1. Methylation
   • Donates methyl groups to DNA, proteins, phospholipids, and neurotransmitter-related pathways.
   • This may alter cell-membrane phospholipids and influence synthesis or metabolism of serotonin, dopamine, and norepinephrine.
   • These effects provide the proposed rationale for its antidepressant activity.
2. Transsulfuration and antioxidant support
   • SAMe metabolism contributes to production of cysteine and glutathione, an endogenous antioxidant.
   • In liver disease, this may support hepatocyte defense against oxidative injury.
3. Aminopropylation
   • Decarboxylated SAMe supplies groups for synthesis of the polyamines spermidine and spermine, which participate in cellular growth and membrane stability. Harper's Illustrated Biochemistry, p. 320.

Uses

• Intrahepatic cholestasis / chronic liver disease
  • Used in some countries as supportive therapy for pruritus and biochemical cholestasis.
  • It does not replace evaluation and treatment of the cause of cholestasis, such as obstruction, viral hepatitis, drug injury, or pregnancy-related disease.
  • A 2024 systematic review found that the liver-health evidence is heterogeneous and that stronger trials are still needed: recent systematic review.
• Depression
  • Sometimes used as monotherapy or, more often, an adjunct to a conventional antidepressant in selected patients.
  • Evidence suggests possible benefit, but it is not a first-line substitute for standard depression assessment and treatment. A 2024 systematic review/meta-analysis assessed SAMe as adjunctive treatment: depression evidence review.
• Osteoarthritis
  • Used in some settings for pain and functional symptoms. Evidence is mixed and it is not routinely preferred over established treatments.
• Other off-label or supplement uses
  • Fibromyalgia and other chronic pain conditions have been studied, but evidence is limited or inconsistent.

Adverse effects

Important precautions and interactions

• Bipolar disorder: Avoid unless managed by a psychiatrist. SAMe can trigger mania or hypomania.
• Serotonergic drugs: Use caution with SSRIs, SNRIs, MAO inhibitors, tricyclic antidepressants, tramadol, linezolid, triptans, dextromethorphan, or St John's wort. Combining these may increase the risk of serotonin toxicity.
• Seek urgent care for agitation, confusion, fever, sweating, diarrhea, tremor, muscle rigidity, fast heartbeat, or severe blood-pressure changes, especially after combining it with antidepressants.
• Pregnancy or breastfeeding: use only under clinician guidance. This is particularly important in suspected intrahepatic cholestasis of pregnancy.
• Do not self-treat jaundice, dark urine, pale stools, severe itch, fever, or right-upper abdominal pain with SAMe. These require medical assessment.

Bottom line

• It is not a standard core therapy in major internal-medicine management pathways for chronic liver disease, cholestatic disorders, depression, or osteoarthritis.
• In practice, it may be used in some countries as an adjunct for intrahepatic cholestasis or chronic liver disease symptoms, but underlying causes must be investigated and treated.
• For depression, it should not replace guideline-based antidepressant therapy, psychotherapy, or assessment for bipolar disorder.
• Main safety issue: possible activation, hypomania, or mania, particularly in bipolar-spectrum illness; caution is also needed with serotonergic antidepressants.